^SAMPLE = GSM795962!Sample_title = Sample 37P_ependymoma-250knsp!Sample_geo_accession = GSM795962!Sample_status = Public on Feb 09 2012!Sample_submission_date = Sep 13 2011!Sample_last_update_date = Feb 09 2012!Sample_type = genomic!Sample_channel_count = 1!Sample_source_name_ch1 = primary ependymoma DNA sample from patient 37!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = patient: 37!Sample_characteristics_ch1 = disease state: ependymoma!Sample_characteristics_ch1 = ependymoma status: primary!Sample_characteristics_ch1 = gender: female!Sample_characteristics_ch1 = location: supratentorial (ST)!Sample_characteristics_ch1 = age: 13.8yrs!Sample_characteristics_ch1 = tumour grade: World Health Organisation Grade II!Sample_characteristics_ch1 = patient outcome: Alive and no disease progression!Sample_characteristics_ch1 = tumour 1q gain status: No 1q gain!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted snap frozen tumour tissue and mononuclear cell preparations  from peripheral blood, using a standard phenol/chloroform/isoamyl alcohol method. DNA quality and quantity was assessed using a Nandrop spectrophotometer and agarose gel electrophoresis.!Sample_label_ch1 = Biotin!Sample_label_protocol_ch1 = As per manufacturer (Affymetrix)!Sample_hyb_protocol = DNA was restriction digested, PCR amplified, fragmented, labelled and hybridised to each array according to the manufacturer's instructions.!Sample_scan_protocol = The Arrays were then washed using Affymetrix fluidics stations, and scanned using the Gene Chip Scanner 3000.!Sample_description = primary ependymoma, female, ST, 13.8yrs!Sample_description = S0398FL0017 nsp!Sample_description = Hybridized to 250K_Nsp!Sample_data_processing = CEL files and CHP files (generated by Affymetrix GTYPE using the BRLMM algorithm) were processed by CNAG. Normalization was performed using the constitutional samples. Data processing was performed as described in Miller et al Neuro Oncol 2011;13(8):866-79.!Sample_data_processing = Primary data description: Genotype Call (SNP call): AA, AB, BB, NC, and NoCall;!Sample_platform_id = GPL3718!Sample_contact_name = John-Paul,,Kilday!Sample_contact_email = mgzjk@exmail.nottingham.ac.uk!Sample_contact_phone = 0115 8230718!Sample_contact_laboratory = D18!Sample_contact_department = CBTRC!Sample_contact_institute = University of Nottingham !Sample_contact_address = Derby Road!Sample_contact_city = Nottingham!Sample_contact_zip/postal_code = NG7 2UH!Sample_contact_country = United Kingdom!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795962/suppl/GSM795962_S0398FL0017-250knsp.CEL.gz!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795962/suppl/GSM795962_S0398FL0017-250knsp.brlmm.chp.gz!Sample_series_id = GSE32101!Sample_data_row_count = 262314#ID_REF = PROBE SET NAME#VALUE = CALL#CONFIDENCE = #FORCED CALL = #CONTRAST = #STRENGTH = !sample_table_beginID_REF	VALUE	CONFIDENCE	FORCED CALL	CONTRAST	STRENGTHAFFX-2315060	AB	0.000155	AB	-0.057556	11.496365AFFX-2315061	BB	0.001956	BB	-0.788120	10.484337AFFX-2315062	AA	0.016712	AA	0.533193	9.778665AFFX-2315057	AB	0.018141	AB	-0.148338	10.047372AFFX-2315058	AA	0.009399	AA	0.686121	10.990134AFFX-2315059	AA	0.022570	AA	0.795322	10.069356AFFX-2315063	AA	0.003010	AA	0.790126	10.013588AFFX-2315064	AB	0.009188	AB	0.280812	10.049647AFFX-2315065	BB	0.005575	BB	-0.626871	10.029867AFFX-2315066	AB	0.003503	AB	-0.088858	9.969095AFFX-2315067	AB	0.000514	AB	0.017919	10.861109AFFX-2315068	AA	0.003347	AA	0.823202	10.257090AFFX-2315069	AB	0.001386	AB	-0.221296	10.368015AFFX-2315070	AB	0.003299	AB	-0.164549	10.066416AFFX-2315071	BB	0.049707	BB	-0.725563	9.492076AFFX-2315072	AA	0.004551	AA	0.536781	10.317575AFFX-2315073	AA	0.014051	AA	0.730502	10.046770AFFX-2315074	AB	0.011329	AB	-0.010716	9.469529AFFX-2315075	AA	0.005783	AA	0.565241	10.939040AFFX-2315076	BB	0.482152	BB	-0.370278	9.911264!sample_table_end